MBL Announces Largest Ever Gift for Its Renowned Biological Education and Research Programs

Cell Biology Researcher Mark Terasaki's $25 Million Unrestricted GiftWill Support Operations and Infrastructure The Marine Biological Laboratory today announced a $25 million gift of unrestricted support from Mark Terasaki,an MBL Whitman Scientist and Associate Professor in the University of Connecticut Health Center's Department of Cell Biology. The gift will provide $5 million annually for the […]

Hims & Hers Health, Inc. Sued for Securities Law Violations – Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights – HIMS

(NYSE:HIMS), NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. (“Hims & Hers Health, Inc.” or the “Company”) (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Hims & Hers Health, Inc. investors who

Hims & Hers Health, Inc. Sued for Securities Law Violations – Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights – HIMS

Hims & Hers Health, Inc. Sued for Securities Law Violations – Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights – HIMS GlobeNewswire July 28, 2025 NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. (“Hims & Hers Health, Inc.” or

Equifax and Qlarifi Partner to Study Impact of Buy Now, Pay Later on Credit Risk and Fraud

Equifax® (NYSE: EFX) a global data, analytics and technology company, and Qlarifi, the first real-time consumer credit database purpose built for Buy Now, Pay Later lending, are partnering to conduct a joint study on the impact of BNPL reporting on credit risk assessments and fraud prevention. https://mma.prnewswire.com/media/448516/Equifax_jpg_Logo.jpg According to a recent survey, more than 50%

PTC Therapeutics Announces FDA Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

Broad labeling inclusive of all disease subtypes for individuals 1 month of age and older – PTC will host a conference call on Monday, July 28th at 5:00 pm ET – PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the U.S. Food and Drug Administration (FDA) has approved SEPHIENCE™ (sepiapterin) for the treatment of children

RCKT LAWSUIT ALERT: Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

(NasdaqGM:RCKT), NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who were adversely affected by alleged securities fraud between February 27,

RCKT LAWSUIT ALERT: Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

RCKT LAWSUIT ALERT: Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline GlobeNewswire July 28, 2025 NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT) of a class action securities lawsuit. CLASS DEFINITION:

Levi & Korsinsky Notifies Shareholders of iRobot Corporation (IRBT) of a Class Action Lawsuit and an Upcoming Deadline

(NASDAQ:IRBT), NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in iRobot Corporation (“iRobot Corporation” or the “Company”) (NASDAQ: IRBT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of iRobot Corporation investors who were adversely affected by alleged securities fraud between January

Northeast Bank Reports Fourth Quarter Results and Declares Dividend

(NasdaqGM:NBN), PORTLAND, Maine, July 28, 2025 (GLOBE NEWSWIRE) — Northeast Bank (the “Bank”) (NASDAQ: NBN), a Maine-based bank, today reported net income of $25.2 million, or $3.00 per diluted common share, for the quarter ended June 30, 2025, compared to net income of $15.1 million, or $1.91 per diluted common share, for the quarter ended

Piedmont Realty Trust, Inc. Releases Second Quarter 2025 Results

(NYSE:PDM), Atlanta, GA, July 28, 2025 (GLOBE NEWSWIRE) — Piedmont Realty Trust (NYSE: PDM) has released its financial and operational results for the second quarter of 2025. Please visit the Investor Relations section of Piedmont's website at https://investor.piedmontreit.com to access the Earnings Release and Supplemental Information. Piedmont has scheduled a conference call and an an

Scroll to Top